pomalidomide has been researched along with azd2858 in 1 studies
| Studies (pomalidomide) | Trials (pomalidomide) | Recent Studies (post-2010) (pomalidomide) | Studies (azd2858) | Trials (azd2858) | Recent Studies (post-2010) (azd2858) |
|---|---|---|---|---|---|
| 623 | 121 | 552 | 8 | 0 | 8 |
| Protein | Taxonomy | pomalidomide (IC50) | azd2858 (IC50) |
|---|---|---|---|
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 0.005 | |
| Glycogen synthase kinase-3 beta | Mus musculus (house mouse) | 0.076 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, F; Jiang, X; Liu, X; Sun, H; Wang, Y; Xu, J; Xu, K; Zhou, J | 1 |
1 other study(ies) available for pomalidomide and azd2858
| Article | Year |
|---|---|
PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases.
Topics: Animals; Enzyme Inhibitors; Glycogen Synthase Kinase 3 beta; HT29 Cells; Humans; Models, Molecular; Neurodegenerative Diseases; PC12 Cells; Proteolysis; Rats; Small Molecule Libraries | 2021 |